Our team is
dedicated to
providing physicians
with the finest
cancer diagnostics.
dedicated to
providing physicians
with the finest
cancer diagnostics.
Leadership
John Hughes, MS, President
John attended the University of Minnesota where he received a Master’s Degree in Electrical Engineering (emphasis on bio-technology) and Bachelor Degrees in Economics and Electrical Engineering. Since 1987, John has been President of Rhythm & Hues Studios, a leading producer of computer generated character animation and visual effects for entertainment and advertising and the recipient of two Academy Awards for Best Visual Effects and several Science and Engineering Academy Awards. Headquartered in Los Angeles with additional facilities in Mumbai, Hyderabad and Kuala Lumpur, Rhythm & Hues has approximately 1000 employees worldwide.
Vivian Lauderdale, MBA, MS, RAC, Chief Regulatory Affairs Officer
Ms Lauderdale’s responsibilities include operations, quality systems and regulatory affairs for laboratory services and manufacturing. She has a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS) qualifying her to manage regulatory affairs for medical devices and pharmaceutical projects. She has over twenty-five years hands-on experience developing medical products – primarily in Quality Systems and/or Operations. Additionally, she is the founder and managing partner of SciBiz Services, LLC, a technical writing and biomedical business management company which specializes in obtaining bio-medical government grants for
David A. Van Echo, MD, Medical Director
David A. Van Echo, MD has been Medical Director of CCC Diagnostics since 2004. He is also the Director of HarborView Cancer Center at Harbor Hospital in Maryland. He has authored over 100 peer-reviewed articles and 150 abstracts/poster sessions in the field of cancer research. He was a senior investigator at NCI until 1981. From 1981 until 2005, he was Head of the New Drug Development Program and Chief Hematology/Oncology (1993-96) at the University of Maryland Greenebaum Cancer Center. This NCI supported program performed studies of HIV, anticancer drugs, animal pharmacology and Phase I, II and III clinical studies.
Stephen Lesko, PhD, Research Director
Stephen Lesko, PhD was a member of the faculty of Johns Hopkins University for more than twenty years, where he established the University’s first imaging system. More recently he served as Research Director of Cell Works, Inc. In this capacity, he designed an imaging system used throughout the biotechnology industry to probe the characteristics of human cells. Dr. Lesko has one issued patent and has three additional patents pending concerning imaging and cancer diagnostics. He has authored/coauthored over 20 technical publications and abstracts/poster sessions.